IN VITRO ACTIVITY OF VANCOMYCIN AND DAPTOMYCIN AGAINST HEALTHCARE-ASSOCIATED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS ISOLATED FROM CLINICAL SPECIMENS
Abstract
ABSTRACT
Objective: The present cross-sectional study was conducted to determine minimum inhibitory concentration (MIC) of daptomycin and vancomycin
to clinical isolates of healthcare-associated-methicillin-resistant Staphylococcus aureus (HA-MRSA).
Methods: Centers for Disease Control and Prevention Criteria were used to define HR infections due to MRSA. Antibiotic susceptibility testing was
done by Kirby–Bauer disk diffusion method. MIC of vancomycin and daptomycin was determined by Agar dilution method and E-test, respectively.
Results of antibiotic susceptibility testing and MIC were interpreted as per Clinical Laboratory Standard Institute guidelines.
Results: A total of 110 strains of MRSA were isolated from healthcare-associated infections. All were susceptible to daptomycin, linezolid, and
teicoplanin. A total of 106 isolates were vancomycin susceptible and four were vancomycin-intermediate S. aureus (VISA). MIC
of
vancomycin were 2 µg/ml. All MRSA isolates were susceptible to daptomycin. Four VISA strains had daptomycin MIC 1 µg/ml.
Conclusion: The present study showed the emergence of VISA among HA-MRSA isolates with high MIC
for vancomycin. Although all HA-MRSA
isolates were susceptible to daptomycin, VISA isolates had high daptomycin MIC. This indicates that daptomycin may not be used as an alternative
choice for VISA infections.
Keywords: Healthcare-associated methicillin-resistant Staphylococcus aureus, Vancomycin, Daptomycin.
90
90
and MIC
50
Downloads
References
REFERENCES
Stefani S, Chung DR, Lindsay JA, Friedrich AW, Kearns AM, Westh H,
et al. Meticillin-resistant Staphylococcus aureus (MRSA): Global
epidemiology and harmonisation of typing methods. Int J Antimicrob
Agents 2012;39(4):273-82.
Indian Network for Surveillance of Antimicrobial Resistance (INSAR)
group, India. Methicillin resistant Staphylococcus aureus (MRSA)
in India: Prevalence and susceptibility pattern. Indian J Med Res
;137(2):363-9.
Hawser SP, Bouchillon SK, Hoban DJ, Dowzicky M, Babinchak T.
Rising incidence of Staphylococcus aureus with reduced susceptibility
to vancomycin and susceptibility to antibiotics: A global analysis 20042009.
Int J Antimicrob
Agents
;37(3):219-24.
Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ,
et al. Clinical practice guidelines by the Infectious Diseases Society
of America for the treatment of methicillin-resistant Staphylococcus
aureus infections in adults and children: Executive summary. Clin
Infect Dis 2011;52(3):285-92.
Centers for Disease Control and Prevention. CDC/NHSN Surveillance
Definition for Specific Types of Infection. Available from: http://
www.cdc.gov/nhsn/pdfs/pscmanual/17pscnosinfdef-current.pdf. [Last
accessed 2015 Nov 13].
Bannerman TL. Staphylococci and other catalase positive cocci that
grow aerobically. In: Murray PR, Baron EJ, Jorgenson JH, editors.
Manual of Clinical Microbiology. 8
th
ed. Washington, DC: ASM Press;
p. 384-404.
Clinical and Laboratory Standards Institute. Performance Standards
For Antimicrobial Susceptibility Testing; Twenty Fifth Informational
Supplement. CLSI Document M100-S25. Wayne, PA: CLSI; 2015.
Clinical and Laboratory Standards Institute. Performance Standards for
Antimicrobial Susceptibility Testing; Twenty –Second Informational
Supplement. CLSI Document M100-S22. Wayne, PA: CLSI; 2012.
Mewara A, Gautam V, Kaur H, Ray P. In vitro evaluation of antibiotics
for methicillin-resistant Staphylococcus aureus from north India. Indian
J Med Res 2014;139(2):319-22.
Thati V, Shivannavar CT, Gaddad SM. Vancomycin resistance among
methicillin resistant Staphylococcus aureus isolates from intensive
care units of tertiary care hospitals in Hyderabad. Indian J Med Res
;134(5):704-8.
Sakoulas G, Moise-Broder PA, Schentag J, Forrest A, Moellering RC Jr,
Eliopoulos GM. Relationship of MIC and bactericidal activity to efficacy
of vancomycin for treatment of methicillin-resistant Staphylococcus
aureus bacteremia. J Clin Microbiol 2004;42(6):2398-402.
Kaur R, Gautam V, Ray P, Singh G, Singhal L, Tiwari R. Daptomycin
Asian J Pharm Clin Res, Vol 9, Issue 3, 2016, 44-46
Kumari et al.
susceptibility of methicillin resistant Staphylococcus aureus (MRSA).
Indian J Med Res 2012;136(4):676-7.
Dhawan B, Gadepalli R, Rao C, Kapil A, Sreenivas V. Decreased
susceptibility to vancomycin in meticillin-resistant Staphylococcus
aureus: A 5 year study in an Indian tertiary hospital. J Med Microbiol
;59:375-6.
Fowler VG Jr, Boucher HW, Corey GR, Abrutyn E, Karchmer AW,
Rupp ME, et al. Daptomycin versus standard therapy for bacteremia
and endocarditis caused by Staphylococcus aureus. N Engl J Med
;355(7):653-65.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.